HORIZON SPEC HOSPITAL-LAS VEGAS
1. Target Overview & Investment Thesis
HORIZON SPEC HOSPITAL-LAS VEGAS is a 100-bed suburban community hospital in CLARK, NV with $44.1M in net patient revenue and a -2.2% operating margin. The hospital serves a payer mix of 36.1% Medicare, 18.8% Medicaid, and 45.1% commercial.
Thesis: Turnaround. Our ML models identify $3.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -2.2% to 5.1% (+736bps).
| Net Revenue HCRIS | $44.1M |
| Current EBITDA COMPUTED | $-990K |
| Operating Margin COMPUTED | -2.2% |
| Occupancy HCRIS | 55.5% |
| Revenue / Bed COMPUTED | $441K |
| Net-to-Gross HCRIS | 53.6% |
| Distress Probability ML | 54.6% |
2. Market Context & Competitive Position
NV has 58 Medicare-certified hospitals with a median operating margin of 0.4%. The target's margin of -2.2% places it below the state median. Among 20 size-comparable peers (50-200 beds), the median margin is 1.9%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (50-200), prioritizing same-state peers. 20 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| HORIZON SPEC HOSPITAL-LAS VEGA (Target) | NV | 100 | $44.1M | -2.2% |
| CARSON TAHOE REGIONAL HEALTHCA | NV | 175 | $365.4M | 3.0% |
| DESERT SPRINGS HOSPITAL MEDICA | NV | 190 | $182.8M | -39.4% |
| ST. ROSE DOMINICAN - SAN MARTI | NV | 130 | $179.5M | -18.6% |
| NORTHERN NEVADA MEDICAL CENTER | NV | 88 | $150.8M | 10.5% |
| NORTH VISTA HOSPITAL | NV | 163 | $117.3M | 9.5% |
| RENOWN SOUTH MEADOWS MED CTR | NV | 78 | $91.0M | 4.0% |
| NORTHEASTERN NEVADA REGIONAL H | NV | 59 | $84.2M | 15.5% |
| NORTHERN NEVADA SIERRA MEDICAL | NV | 158 | $61.7M | -50.0% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $3.2M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $926K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $881K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $873K | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $536K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $28K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-990K |
| + RCM Uplift | +$3.2M |
| Pro Forma EBITDA | $2.3M |
| Current Margin | -2.2% |
| Pro Forma Margin | 5.1% |
| WC Released (1x) | $1.7M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-1.5M | $25.9M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-1.5M | $28.0M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-1.4M | $38.2M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-1.4M | $41.3M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-1.7M | $10.2M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-1.7M | $10.7M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| High | Elevated distress probability | Model estimates 54.6% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 20 hospitals with 50-200 beds
- Same-state prioritization (n=21)
- Comp margins: P25=-13.0% / P50=1.9% / P75=9.7%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.